How to Hack a $1.3T Market
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
About Regeneron Pharmaceuticals, Inc
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia (HoFH) or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; Evkeeza for treatment of HoFH; Ordspono for Follicular lymphoma and Diffuse large B-cell lymphoma; and Veopoz for CD55-deficient protein-losing enteropathy. Further, it develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types; and with Sonoma Biotherapeutics, Inc. to discover, develop, and commercialize engineered regulatory T cell therapies. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.
General
| Name | Regeneron Pharmaceuticals, Inc |
| Ticker | REGN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 15,158 |
Highlights
| Analyst Target | 727.67 |
| Market Cap | 58,890,900,000 |
| PE Ratio | 13.88 |
| PEG Ratio | 1.17 |
| EBITDA | 4,471,000,064 |
Share Stats
| Shares Outstanding | 106,400,000 |
| Shares Float | 104,070,000 |
| Shares Short | 2,070,000 |
| Insider Holdings | 189% |
| Institution Holdings | 91.92% |
Highlights
| Analyst Target | 727.67 |
| Market Cap | 58,890,900,000 |
| PE Ratio | 13.88 |
| PEG Ratio | 1.17 |
| EBITDA | 4,471,000,064 |
Valuation
| Trailing PE | 14.10 |
| Forward PE | 15.50 |
| Price/Sales (Trailing 12 Mt.) | 4.25 |
| Price/Book (Most Recent Quarter) | 2.04 |
Dividend
Regeneron Pharmaceuticals, Inc pays out a dividend of $2.83 per share, with a dividend yield of 0.52%.
REGN's last dividend payment was made to shareholders on June 6, 2025.
They pay out 0.00% of their earnings out as a dividend.
Recent Dividends
| Jun 6, 2025 | $0.88 |
| Mar 20, 2025 | $0.88 |
Jim Cramer Recommends This 'Really, Really Good' Energy Stock
Cramer also looks at Shutterstock and Getty. One of these companies "doesn't really have the growth" that he'd like to see.
Why Is Donald Trump Ignoring Elon Musk's Call For 'Phase 2' Of The Epstein Files?
Musk's post questioning Trump's unfulfilled promise of Epstein-related disclosures reignites tensions over transparency in politics and tech.
Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Coldplay's jumbotron captures — what exactly? The internet has its theories
LONDON (AP) — It started out as a routine bit of fun at a Coldplay concert: Lead singer Chris Martin asked the cameras to scan the crowd for his “Jumbotron Song,” when he sings a few lines about the people the camera lands on.
Charles Schwab To Launch Bitcoin, Ethereum Trading Services
Charles Schwab (NYSE:SCHW), one of the largest brokerage firms in the United States, has confirmed plans to launch Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO:
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
AMD Stock Is Sliding Tuesday: What's Driving The Action?
Shares of Advanced Micro Devices are trading lower Tuesday afternoon. The stock is caught in a broader downturn affecting the semiconductor industry.
At 14, Jamie Dimon Owned His First Stock, Watched A 45% Market Crash Only To Learn This Investment Lesson: 'History Does Rhyme'
Jamie Dimon, the CEO of JPMorgan Chase & Co., revealed the pivotal investment lesson he learned as a teenager.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Trump-Backed DOJ Motion Seeks Release Of Jeffrey Epstein, Maxwell Grand Jury Transcripts
DOJ moves to unseal grand jury testimony related to Jeffrey Epstein and Ghislaine Maxwell following criticism over handling of documents.
Russia insists on achieving Ukraine goals despite Trump's ultimatum
Russia is open to peace with Ukraine, but achieving its goals remains a priority, Kremlin spokesman Dmitry Peskov said Sunday, days after U.S. President to agree to a ceasefire or .
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Bitcoin's 4-Year Cycle Is Dead, Researcher Says: Here's Why It Matters For XRP
The crypto market has changed, and experts say relying on the traditional 4-year halving cycle could leave investors poorly positioned in
When Jamie Dimon's Daughter Asked If They Have To 'Sleep On Streets' After He Was Fired From Citigroup: 'It Was My Net Worth, Not My Self-Worth...'
Jamie Dimon, recently shared a personal anecdote about the day he was fired from Citigroup and the impact it had on his family and career.
What's inside Elon's building in Memphis will shock you - Ad
Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the August 1st funding window closes.
Can you ever expect privacy in public? Coldplay kiss camera saga tells us a lot about the answer
NEW YORK (AP) — When the landed on a couple who tried (but failed) to duck out of the spotlight, the internet immediately got to work.
Trump Diagnosed With Chronic Venous Insufficiency, A Common Circulatory Condition In Over-70s, White House Says He's 'In Excellent Health'
The White House revealed President Trump is diagnosed with chronic health condition.
Don't Touch Tesla Stock Without Reading This First - Ad
Jeff Brown, an early Tesla bull, warns of a strange "Tesla Glitch" uncovered by Wall Street legend Larry Benedict. This anomaly has preceded $25B-$100B swings in Tesla's value - and he's using it to anticipate moves without buying or shorting a single share.
Elon Musk's Tesla Sits On $284 Million Bitcoin Windfall In Q2, Refuses to Cash Out
Electric vehicle behemoth Tesla Inc.
Ethereum, XRP, SOL Surge After GENIUS Act: What's Driving The Altcoin Rally?
The altcoin rally may only be getting started and follows the signing of the GENIUS Act, the most significant U.S. crypto legislation to date, ushering in structural clarity for digital assets.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Typhoon Wipha topples trees and causes major flight disruptions in Hong Kong and southern China
HONG KONG (AP) — Typhoon Wipha toppled trees and caused major flight disruptions Sunday in and at some nearby airports in China as it moved west off the southern coast of .
XRP Falls Nearly 2.5% As Ripple Co-Founder Transfers $150 Million Worth Of Coins From Wallet — Analyst Says, 'He's Dumping On You'
A wallet tied to Ripple co-founder and executive chairman Chris Larsen transferred out hundreds of millions worth of XRP (CRYPTO: XRP) over the last week.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
Jack Dorsey's Block, With Over $1 Billion In Bitcoin Holdings, Set To Join S&P 500 — Shares Pop 8% In Overnight Trading
Block, Inc. (NYSE:XYZ) shares are soaring in overnight trading on Sunday ahead of the S&P 500 debut of the Jack Dorsey-founded fintech company.
Chevron gets go ahead for $53B Hess deal, and access to one of the biggest oil finds this decade
HOUSTON (AP) — Chevron has scored a critical ruling in Paris that has given it the go-ahead for a $53 billion acquisition of Hess and access to one of the biggest oil finds of the decade.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Connie Francis' 'Pretty Little Baby' became an unexpected TikTok hit — 63 years after its release
Connie Francis was a giant of 1950s and '60s sugary-sweet pop, notching more than a dozen hits. In the months she experienced one more in “Pretty Little Baby,” which has become a viral hit on TikTok six decades after its release.
EU and Japan agree to work together to promote free trade and economic security
TOKYO (AP) — Leaders of the and Japan launched an alliance Wednesday aimed at boosting economic cooperation, defending free trade and countering unfair trade practices as the two sides face growing challenges from the United States and China.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Elon Musk's X Accused Of Algorithm Manipulation And 'Fraudulent Data Extraction' In France: Telegram's Pavel Durov Says Any Tech Company Can Now Be Called A 'Criminal Gang'
Telegram CEO Pavel Durov criticized France's criminal probe into Elon Musk's X, warning that labeling tech firms as "criminal gangs" threatens free speech and deters innovation.
Cathie Wood Pounces On Tesla Dip: Ark Snaps Up $43.7 Million In EV Stock While Ditching Crypto Shares Amid Bitcoin Frenzy
On Thursday, Cathie Wood-led Ark Invest made significant trades, prominently featuring the purchase of Tesla Inc. (NASDAQ:TSLA) shares across multiple ETFs.
Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Benzinga Bulls And Bears: T-Mobile, LendingTree, Molina Healthcare — And Trade Deal Optimism Boosts Markets
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Business News Digest
AP Business Digest
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
BlackSky Technology Stock Tumbled On Tuesday: What Happened?
BlackSky Technology Inc. (NYSE: BKSY) shares fell nearly 10% on Tuesday after Canaccord Genuity cut its price target on the stock.
Stellantis warns of $2.7 billion loss for 1st half of 2025 due to tariffs and some big charges
Stellantis, the maker of Jeep and Ram vehicles, says its preliminary estimates show a 2.3 billion euros ($2.68 billion) net loss in the first half of the year due to U.S. tariffs and some hefty charges.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Circle CEO: Stablecoins Are Going Mainstream — Fast
Jeremy Allaire, CEO of Circle Internet Group, Inc. (NYSE:CRCL), is offering a compelling vision for the future of digital finance and the role of stablecoins in the global economy.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.